Hyaluronic acid-based nanocomplexes have been developpend as novel drug-nanocarriers to treat myotonic dystrophy

Hyaluronic acid-based nanocomplexes as novel drug-nanocarriers to treat myotonic dystrophy

M. Repellin
;
F. Carton;F. Boschi;M. Malatesta
2019-01-01

Abstract

Hyaluronic acid-based nanocomplexes have been developpend as novel drug-nanocarriers to treat myotonic dystrophy
2019
nanoparticles, hyaluronic acid, myotonic dystrophy
File in questo prodotto:
File Dimensione Formato  
3052-Article Text-20695-3-10-20190702.pdf

accesso aperto

Tipologia: Versione dell'editore
Licenza: Dominio pubblico
Dimensione 52.06 kB
Formato Adobe PDF
52.06 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1000931
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact